Actively Recruiting

Age: 18Years - 65Years
All Genders
NCT07057765

Predictive Value of CRP, Albumin, CAR, and mGPS in Treatment Outcomes of DLBCL

Led by Ain Shams University · Updated on 2025-07-10

40

Participants Needed

1

Research Sites

64 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This observational study evaluates the predictive value of systemic inflammatory markers-CRP, albumin, CRP-to-albumin ratio (CAR), and modified Glasgow Prognostic Score (mGPS)-in patients with diffuse large B-cell lymphoma (DLBCL) receiving R-CHOP chemotherapy. The study examines associations with treatment response, toxicity, and clinical characteristics.

CONDITIONS

Official Title

Predictive Value of CRP, Albumin, CAR, and mGPS in Treatment Outcomes of DLBCL

Who Can Participate

Age: 18Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 to 65 years
  • Pathologically confirmed, treatment-nave diffuse large B-cell lymphoma (DLBCL)
  • Any disease stage (nodal or extra-nodal), with or without B symptoms
  • Scheduled to receive standard systemic treatment with R-CHOP chemotherapy
  • ECOG performance status between 0 and 2
  • Baseline normal complete blood count (CBC), hepatitis viral markers, liver and renal function tests, urine analysis, and echocardiogram
  • Additional investigations to rule out current infection if clinically indicated
Not Eligible

You will not qualify if you...

  • History of other concurrent or previous malignancies
  • Relapsed or refractory diffuse large B-cell lymphoma
  • Uncontrolled comorbid conditions including diabetes mellitus, autoimmune diseases, active infections, chronic inflammatory diseases, cardiac dysfunction, or liver cell failure
  • Pregnant females

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Clinical Oncology and Nuclear Medicine Department, Faculty of Medicine, Ain Shams University

Cairo, Cairo Governorate, Egypt, 1181

Actively Recruiting

Loading map...

Research Team

A

Alaa M Elsayed, MSc

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Predictive Value of CRP, Albumin, CAR, and mGPS in Treatment Outcomes of DLBCL | DecenTrialz